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Abstract
Background: The aim of the present study was to determine whether stage of invasiveness of
bladder cancer cell lines contributes to alterations in glycan pattern of their cadherins.
Results: Human non-malignant epithelial cell of ureter HCV29, v-raf transfected HCV29 line
(BC3726) and transitional cell cancers of urine bladder Hu456 and T24 were grown in cell culture.
Equal amounts of protein from each cell extracts were separated by SDS-PAGE electrophoresis
and were blotted on an Immobilon P membrane. Cadherins were immunodetected using anti-pan
cadherin mAb and lectin blotting assays were performed, in parallel. N-oligosaccharides were
analysed by specific reaction with Galanthus nivalis agglutinin (GNA), Sambucus nigra agglutinin
(SNA), Maackia amurensis agglutinin (MAA), Datura stramonium agglutinin (DSA), Aleuria aurantia
agglutinin (AAA), Phaseolus vulgaris agglutinin (PHA-L) and wheat germ agglutinin (WGA). The
cadherin from HCV29 cell line possessed bi- and/or 2,4-branched triantennary complex type
g l y c a n s ,  s o m e  o f  w h i c h  w e r e  α 2,6-sialylated. The cadherin from BC3726 cell line exhibited
exclusively high mannose type glycans. Cadherins from Hu456 and T24 cell lines expressed high
mannose type glycans as well as β 1,6-branched oligosaccharides with poly-N-acetyllactosamine
structures and α 2,3-linked sialic acid residues. Additionally, the presence of fucose and α 2,6-sialic
acid residues on the cadherin from T24 cell line was detected.
Conclusions: These results indicate that N-glycosylation pattern of cadherin from bladder cancer
cell line undergoes modification during carcinogenesis.
Background
Cadherins comprise a family of calcium-dependent trans-
membrane cell-cell adhesion molecules, generally
thought to be homophilic cell adhesion proteins [1]. The
homophilic binding of cadherins is regulated by extracel-
lular and intracellular signals, which modulate cadherin
activity [2] without a concomitant changes in cadherin ex-
pression. Nevertheless, the signals that modulate cadherin
activity are not completely characterized.
Being cell surface proteins, cadherins are glycosylated [3].
Protein-linked carbohydrates determine protein stability,
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activity and specificity of interaction, and they are also in-
volved in cell-cell and cell-matrix recognition [4]. Distur-
bances in cadherin-based adhesion contribute to tumor
progression in a range of epithelium tumors [5].
Yoshimura et al. [6] have shown that the suppression of
metastasis in murine melanoma B16-hm cells expressing
N-acetylglucosaminyltransferase III was at least partly due
to increased level of glycosylated E-cadherin. The authors
imply that glycosylation is one of the important events in
the process of metastasis.
Despite the increasing number of studies on structure and
biological function of cadherins, little is known about car-
bohydrate chains structure of these glycoproteins and its
role. It is indispensable for us to know the changes in gly-
cosylation pattern of adhesion molecules, for example
cadherins, in both normal and malignant tissues in order
to promote a better understanding of the roles of these
carbohydrate structures in physiological and pathological
processes. Thus, the aim of our study was to perform a pre-
liminary characterization of carbohydrate structure of
cadherins from human non-malignant epithelial cells of
ureter (HCV29), v-raf transfected HCV29 cell line (BC
3726) and human transitional cell cancers of urinary
bladder (Hu456 and T24) using highly specific digoxigen-
in-labeled lectins.
Results
The results of glycan chain analysis of cadherins are
shown in Fig. 1. The specificities of the lectins used are
summarized in Table 1. The results revealed some differ-
ences in glycosylation patterns of cadherins from normal
and cancer cell lines. The presence of high mannose type
oligosaccharides was ascertained in cadherins from
BC3726, Hu456 and T24 cell lines as indicated by the pos-
itive reaction with GNA. The specific reaction with PHA-L
indicated the existence of GlcNAcβ 1,6-branched trianten-
nary and/or tetraantennary complex type glycans on cad-
herins from Hu456 and T24 cell lines. The DSA binding to
cadherin from HCV29 cell line indicated the presence of
terminal disaccharide(s) Galβ 1,4GlcNAc (N-acetyllactos-
amine unit) in biantennary complex type and/or in 2,4-
branched triantennary species. Moreover, positive reac-
tion with both DSA and PHA-L, observed for cadherins
from bladder cancer Hu456 and T24 cell lines, suggested
the presence of poly-N-acetyllactosamine units on 2,6-
branched triantennary and/or tetraantennary structures.
The sialic acid residue(s) occupying the terminal position
in N-linked oligosaccharides of cadherins were found to
be in Galα 2,3-linkage in Hu456 and T24 cell lines (posi-
tive reaction with MAA), or in Galα 2,6-linkage in HCV29
and T24 cell lines (positive reaction with SNA). Addition-
ally, positive reaction with AAA confirmed the existence of
fucose residue(s) on cadherin from T24 cell line. AAA
binds Fucα 1,6-linked to the proximal GlcNAc residue as
well as a Fucα 1,2Galβ 1,4GlcNAc- sequence (blood group
H(O) determinant) and a Galβ 1,4(Fucα 1,3)GlcNAc- se-
quence (Lex determinant) [7]. No evidence for the pres-
ence of bisected species and/or branching poly-N-
acetyllactosamine species on examined cadherins from all
cell lines was found (negative reaction with WGA, data
not shown) [7].
Immunodevelopment of the Western blots of protein cell
extracts with anti-pan cadherin antibodies revealed a po-
sition of cadherin molecules on the blots and it allowed
to estimate the molecular weight of examined glycopro-
teins. Cadherin from non-malignant HCV29 cell line
showed lower apparent molecular weight (130 kDa) than
its cancer counterparts (131 kDa in Hu456 and 135 kDa
in BC3726 and T24). These findings are consistent with
well-documented phenotypic alternation of the trans-
formed cells [8].
Discussion
Previously, we had established that the adhesion mole-
cules, expressed in all mentioned above cell lines, which
reacted with anti-pan cadherin monoclonal antibodies
were N-cadherins except the HCV29 non-malignant ureter
cell line [9]. In this cell line only trace amounts of N-cad-
herin were detected. Moreover, neither this nor any other
examined cancer cell lines expressed E-cadherin [9]. Frix-
en et al. [10] found that differentiated human cancer cell
lines, including bladder cell lines, generally expressed E-
cadherin and were noninvasive in vitro, whereas dediffer-
entiated cell lines did not express this cell-cell adhesion
molecule and were invasive. It is well-documented that, in
a wide range of cancers, E-cadherin expression is loss or
Table 1: Sugar binding specificities of lectin used for lectin blot-
ting studies (lectin assays).
Lectin Lectin-specific glycan structure
GNA Manα 1,2Man-
Manα 1,6Man-
Manα 1,3Man-
SNA NeuAcα 2,6Gal-
MAA NeuAcα 2,3Gal-
DSA Galβ 1,4GlcNAc-
AAA Fucα 1,6GlcNAc-Asn
Fucα 1,2Galβ 1,4GlcNAc-
Galβ 1,4(Fucα 1,3)GlaNAc-
PHA-L Galβ 1,4GlcNAcβ 1,6(Galβ 1,4GlcNAcβ 1,2)
Manα -
WGA GlcNAcβ 1,4Man-
NeuAα Gal-
GlcNAcβ 1,4GlcNAc-Cancer Cell International 2002, 2 http://www.cancerci.com/content/2/1/6
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downregulated, resulting in a reduced level of intracellu-
lar adhesion, and perturbation in E-cadherin-mediated
cell adhesion is involved in tumor progression and metas-
tasis [7,11–15]. Giroldi et al. [16] showed that N-cadherin
become predominantly expressed in bladder-cancer cell
lines that have lost E-cadherin expression.
Mialhe et al. [17] observed that T24 cells were poorly dif-
ferentiated but had yet a typical epithelial morphology.
T24 cells possessed an N-cadherin-dependent adhesiv-
ness. The authors found that T24 cells lacked completely
E-cadherin expression. These findings suggested that N-
cadherin could play a role in bladder carcinogenesis, espe-
cially in E-cadherin-negative, poorly differentiated cells.
In various cancers [18–20]), including bladder cancer re-
duced E-cadherin expression has been shown to correlate
with progression of disease. Mialhe et al. [17] hypothe-
sized that, N-cadherin expressed in T24 bladder cell, a
highly invasive tumor, could play a major role in acquisi-
tion of invasive phenotype. Thus, it is not surprising, that
bladder cancer cell line which we examined did not ex-
press E-cadherin molecules. However, the lack of E-cad-
herin expression in the non-malignant HCV29 cell line
was not expected since normal epithelium strongly ex-
presses E-cadherin [21]. It is conceivable that a lack of E-
cadherin may be a phenomenon characteristic for in vitro
culture of HCV29 cell line [9].
It is well known that tumorigenesis and metastasis are fre-
quently associated with altered structure and expression
of oligosaccharides on cell surface glycoproteins and gly-
colipids [8,22–25]. Therefore, we suspected that the cad-
herins from human cancers cell lines originated from
ureter and bladder tissues, might represent, in comparison
with cadherin from non-malignant HCV29 cell line differ-
ent glycosylation patterns. Our study confirmed this ex-
pectation and demonstrated that cadherin from non-
malignant HCV29 cell line possessed bi- and/or 2,4-
branched triantennary complex type glycans, some of
which were α 2,6-sialylated. The glycosylation pattern ob-
served for N-cadherin from BC3726 cell line was, in com-
parison with cadherin from parental HCV29 cell line,
Figure 1
Extracts from cell lines: HCV29, BC3726, Hu456 and T24 (100 µg of total protein) were run on 8% PAGE/SDS and blotted
onto Immobilon P membrane and probed with lectins: GNA, MAA, SNA, PHA-L, DSA and AAA. Immuno-cadherin probed
with anti-pan cadherin mAbs. (+) Positive reaction with lectin, (-) negative reaction with lectin.Cancer Cell International 2002, 2 http://www.cancerci.com/content/2/1/6
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dramatically different. Interestingly, this N-cadherin pos-
sessed exclusively high mannose type glycans. This find-
ing indicated that v-raf transfection of parental cells
suppressed the synthesis of complex type glycans on N-
cadherin molecules. This may cause disturbance in inter-
cellular interaction mediated by these adhesion mole-
cules.
On the contrary, bladder cancer cells of Hu456 and T24
cell lines showed ability to generate more complex gly-
cans on cadherins than HCV29 cell line. The basic N-oli-
gosaccharide structures recognised on cadherins from
bladder cancer Hu456 and T24 cell lines were high man-
nose type as well as 2,6-branched tri- and/or tetrantennary
poly-N-acetyllactosamine complex type oligosaccharides.
Some of complex species were α 2,3- or α 2,3- and α 2,6-si-
alylated in N-cadherins from Hu456 or T24 cell lines, re-
spectively. Additionally, N-cadherin from highly invasive
tumor T24, possessed also core fucosylated and/or
Fucα 1,2 and Fucα 1,3 substituted carbohydrates. It has
been demonstrated that the presence of poly-N-acetyllac-
tosamine structures appears to be essential for metastatic
potential of lymphoid tumor cell line and sublines of hu-
man colon cancers [26]. Also, increased branching of N-
linked glycans is a common feature of most malignant
cells. In several model systems, malignant transformation,
tumor cell invasiveness and metastatic potential were
shown to be associated with increased levels of
GlcNAcβ 6Manα 6Manβ 4-R branches of complex N-gly-
cans [27]. It was suggested that poly-N-acetyllactosamine
chains contributed to the metastatic potential by dimin-
ishing cell-substratum adhesion and thereby facilitating
tumor cell invasion [27]. Examining the glycosylation pat-
tern of Hu456 and T24 we could observe that the higher-
grade classification had a cell line in which the glycosyla-
tion pattern was more changed. The donor of Hu456 cells
was a male patient, aged 72, with urinary bladder cancer
grade I [28], whereas the line T24 was obtained from a 82-
year-old female patient with urinary bladder cancer grade
III [29]. Both cancer lines were enriched in high mannose
type glycans, but only cadherins from T24 were core fuco-
sylated and also possessed α 2-6 linked glycans. Thus, fuc-
osylation and α 2,6-sialylation in bladder cancer correlate
with poor prognosis and patient survival. We found quite
similar results for N-cadherins from human metastatic
melanoma cell lines [30].
At present we can only speculate on the physiological role
that the cadherins glycans play. Although it is well estab-
lished that covalentely linked oligosaccharide chains can
be involved in such fundamental biological process as cel-
lular adhesion, their role in the case of individual glyco-
protein is usually enigmatic. Moreover, more invasive cell
lines are characterized by fewer cell-to-cell junctions. It
was suggested that N-cadherin mediates a less stable or
more dynamic intercellular adhesion than that of E-cad-
herin and may make possible detachment and heterotypic
interactions with surrounding cells. We postulate that al-
tered glycosylation can repel intercellular interaction and
sterically prevent cell adhesion molecules such as cadher-
ins from achieving intermolecular distances necessary for
effective interactions.
Materials and Methods
Subjects
Human bladder cancer cell lines (Hu456, T24, BC3726)
and human non-malignant ureter epithelium cell line
(HCV29) were kindly donated by Prof. Danuta Dus ´ , Insti-
tute of Immunology and Experimental Therapy, PAN,
Wrocław, Poland. All cell lines were cultured and cell ex-
tract proteins were prepared as described in [9].
SDS-PAGE and Western blotting
Equal amounts of total protein (100 µg) from all cell ex-
tracts were electrophoresed on 8% SDS-polyacrylamide
gels under reducing conditions according to Laemmli
[31]. Western-blotting on PVDF membranes (Millipore)
was performed according to [32] at 250 mA for 18 h at
4°C.
Immunodetection of cadherins
The immunodetection of cadherins was performed with a
1/500 dilution of mouse anti-pan cadherin monoclonal
antibodies (Sigma) in 0.1% Tween/TBS, 1% BSA for 18 hs
at room temperature and with alkaline phosphate cou-
pled goat anti-mouse immunoglobulin (Roche) (a 1/500
dilution of IgG in 0.1% Tween/TBS, 1% BSA) for 1 h at
room temperature.
Lectin assays
Glycan chains analysis of cadherins was performed ac-
cording to the procedure described by the manufacturer of
the Glycan Differentiation Kit (Roche).
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